From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
|Videos|December 31, 2021
Expert: We Cannot Forget the Importance of Addressing Health Disparities, Improving Health for All in 2022
Laura Lee Hall, PhD, president of the Center for Sustainable Health Care Quality and Equity (SHC), addresses her hopes for the future of SHC’s diabetes DRIVE program and its adoption within health systems.
Advertisement
Pharmacy Times interviewed Laura Lee Hall, PhD, president of the Center for Sustainable Health Care Quality and Equity (SHC), on some new approaches to address racial and ethnic disparities in diabetes care.
During the discussion, Hall addresses her hopes for the future of SHC’s diabetes DRIVE program and its adoption within health systems.
Advertisement
Related to this article
Joshua J. Neumiller, PharmD, CDCES, of the American Diabetes Association discusses pharmacists’ role in diabetes and CKD care from ASN Kidney Week 2026
Jai Radhakrishnan, MD, MBBS, MS, FASN, discusses why IgG4-related kidney disease is often missed and what the MITIGATE subgroup data presented at ASN Kidney Week 2026 show.
Two Kidney Week 2026 analyses tie SGLT2 inhibitors to kidney, CV, and survival gains in T2D, yet over half of patients with diabetic CKD receive neither.
Pharmacy Times featured experts on kidney function assessment, IgG4-related disease, emerging CKD therapies, and gaps in cardiorenal care.
Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.
Sea buckthorn is a commonly used herbal for respiratory health—US pharmacists are knowledgeable in educating patients on herbals, especially during cold and influenza season.
Kidney Week 2026 posters show low-density lipoprotein cholesterol (LDL-C) fell by half in patients receiving dialysis, and oral enlicitide needed no dose adjustment for renal impairment.
Advertisement
Advertisement
Trending on Pharmacy Times
1
PCSK9 Inhibition Lowers LDL-C in Patients With Kidney Disease
2
The Growing Role the Specialty Pharmacy Team Plays in Helping Breast Cancer Patients Navigate Treatment
3
Kidney Week 2026: Pharmacists' Growing Role in Kidney Care
4
GLP-1 RAs Tied to Lower Kidney Failure Risk in Patients With Obesity, CKD
5